U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07603713) titled 'Efficacy and Safety of LP-005 Injection in Patients With Moderate-to-Severe Periodontitis' on April 23.

Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical study designed to evaluate the clinical efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of multiple local injections of different doses of LP-005 injection in patients with moderate-to-severe periodontitis, and to investigate changes in biomarker levels.

Study Start Date: May 01

Study Type: INTERVENTIONAL

Condition: Periodontitis

Intervention: DRUG: LP-005 Injection

LP-005 is a bifunctional antibody f...